DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••••••• H••••••• S••
Biotechnologygroup grade Aon a schedule nowsponsor unattributed
Also written as: A••••••• H••••••• SA; Biotechnology; Fixed Rate; Tranche A Fixed Rate; Tranche B Fixed Rate
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$281,000
n/a on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
2 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| notes lien unstated exited Jun 30, 2024 | at least $61.4M | 101c | 12.00% | Nov 16, 2026 | 1 |
| first lien term loan first lien exited Sep 30, 2023 | at least $60.3M | 98c | 8.50% PIK 3.50% | Nov 16, 2026 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | equity equity C••••• S•••• 1 | n/a | $281,000 370c | |
| O•••••• S•••••••• L•••••• C••• | equity equity C••••• S•••• 2 | n/a | $0 0c |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $0 | $0 | n/a | 0 |
| Mar 31, 2026 | 1 | $0 | $0 | n/a | 0 |
| Dec 31, 2025 | 1 | $0 | $0 | n/a | 0 |
| Sep 30, 2025 | 1 | $0 | $0 | n/a | 0 |
| Jun 30, 2025 | 1 | $0 | $0 | n/a | 0 |
| Mar 31, 2025 | 1 | $0 | $0 | n/a | 0 |
| Dec 31, 2024 | 1 | $0 | $0 | n/a | 0 |
| Sep 30, 2024 | 1 | $0 | $0 | n/a | 0 |
| Jun 30, 2024 | 1 | $61.4M | $61.4M | 101c | 0 |
| Mar 31, 2024 | 1 | $61.4M | $60.8M | 100c | 4 |
| Dec 31, 2023 | 1 | $61.4M | $59.7M | 98c | 4 |
| Sep 30, 2023 | 1 | $121M | $117M | 98c | 8 |
| Jun 30, 2023 | 1 | $60.3M | $58.7M | 98c | 4 |
| Mar 31, 2023 | 1 | $59.3M | $58.1M | 99c | 4 |
| Sep 30, 2022 | 1 | $47.6M | $47.3M | 101c | 0 |
What changed
- Facility left every BDC scheduleJun 30, 2024
- Maturity extended (observed)Sep 30, 2023
- Facility left every BDC scheduleSep 30, 2023
- New borrower on a BDC scheduleSep 30, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- ALVOTECHderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Biotechnologyreportedas one filer wrote it